CurrentEndo
Get Weekly

CurrentEndo coverage · page 34 of 55

Diabetes, Obesity and Metabolism

Briefs 1,321–1,360 of 2,200 CurrentEndo has covered from this journal, newest publication first

Latest from Diabetes, Obesity and Metabolism

All coverage, newest first

  1. Diabetes Obes Metab

    A biweekly DPP ‐4 inhibitor cofrogliptin monotherapy in Chinese patients with impaired glucose tolerance: A phase 2, multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group trial

    Randomized controlled trialT2D & other

  2. Diabetes Obes Metab

    The effect of HbA1c variability on the efficacy of intensive blood pressure control in patients with type 2 diabetes

    Secondary analysisT2D & other

  3. Diabetes Obes Metab

    Intermittent fasting for weight management and metabolic health: An updated comprehensive umbrella review of health outcomes

    Meta-analysisObesity

  4. Diabetes Obes Metab

    Safety, pharmacokinetics and pharmacodynamics of multiple‐dose noiiglutide ( SHR20004 ), a novel GLP ‐1 receptor agonist, in Chinese obese subjects without diabetes mellitus

    Randomized controlled trialObesity

  5. Diabetes Obes Metab

    Hepatic lipogenesis marked by GCKR ‐modulated triglycerides increases serum FGF21 in children/teens with obesity

    Research articleObesity

  6. Diabetes Obes Metab

    SGLT2 inhibition improves endothelium‐independent vasodilatory function in type 2 diabetes: A double‐blind, randomized, placebo‐controlled crossover trial

    Randomized controlled trialT2D & other

  7. Diabetes Obes Metab

    Development of a predictive model for gastrointestinal side effects of metformin treatment in Chinese individuals with type 2 diabetes based on four randomised clinical trials

    Diagnostic or prognostic studyT2D & other

  8. Diabetes Obes Metab

    Similar weight loss with semaglutide regardless of diabetes and cardiometabolic risk parameters in individuals with metabolic dysfunction‐associated steatotic liver disease: Post hoc analysis of three randomised controlled trials

    Secondary analysisLipids & liver

  9. Diabetes Obes Metab

    Role of the liver in the sustained normalisation of A1c over 2 years following short‐term insulin therapy in early type 2 diabetes

    Secondary analysisT2D & other

  10. Diabetes Obes Metab

    The effect of altered sleep timing on glycaemic outcomes: Systematic review of human intervention studies

    Meta-analysisT2D & other

  11. Diabetes Obes Metab

    Is low‐dose glucagon needed and effective in preventing fasted exercise‐induced hypoglycaemia in type 1 diabetes treated with the MiniMed 780G , an automated insulin delivery system?

    Randomized controlled trialTechnology

  12. Diabetes Obes Metab

    Treatment persistence, adherence and healthcare resource utilisation for iGlarLixi versus basal–bolus insulin or premixed insulin in older adult ethnic minorities with type 2 diabetes: SoliEthnicity study

    Cohort studyT2D & other

  13. Diabetes Obes Metab

    High‐protein vegan and omnivorous diets improve peripheral insulin sensitivity to a similar extent in people with type 2 diabetes

    Randomized controlled trialT2D & other

  14. Diabetes Obes Metab

    Postnatal glycaemic outcomes in women with high‐risk gestational diabetes: Identifying key predictors for early intervention

    Cohort studyDiabetes in pregnancy

  15. Diabetes Obes Metab

    Effect of dapagliflozin on renal haemodynamics in hyperfiltering T2D patients

    Randomized controlled trialT2D & other

  16. Diabetes Obes Metab

    Psychosocial outcomes in a diverse sample of youth and their families who initiated continuous glucose monitoring within the first year of type 1 diabetes diagnosis

    Cohort studyTechnology

  17. Diabetes Obes Metab

    Three decades of glucose‐lowering therapy in patients at high cardiovascular risk — A real‐world analysis

    Cohort studyT2D & other

  18. Diabetes Obes Metab

    Differential effects of imeglimin and metformin on insulin and incretin secretion—An exploratory randomized controlled trial

    Randomized controlled trialT2D & other

  19. Diabetes Obes Metab

    Effect of exercise on plasma insulin levels in individuals with type 1 diabetes: A systematic review and meta‐analysis

    Meta-analysisT1D

  20. Diabetes Obes Metab

    Network Mendelian randomisation analysis deciphers protein pathways linking type 2 diabetes and gastrointestinal disease

    Research articleT2D & other

  21. Diabetes Obes Metab

    Individual and joint associations of obesity and metabolic health parameters on arterial stiffness: Evidence from the UK Biobank

    Cross-sectional studyObesity

  22. Diabetes Obes Metab

    Natriuretic peptide levels and predicting risk of developing new diabetes mellitus and metabolic syndrome

    Cohort studyT2D & other

  23. Diabetes Obes Metab

    Inclisiran versus alirocumab in improving lipid profile parameters: A systematic review and meta‐analysis

    Meta-analysisLipids & liver

  24. Diabetes Obes Metab

    Association of ‘weekend warrior’ and other leisure time physical activity patterns with obesity and adiposity: A cross‐sectional study

    Cross-sectional studyObesity

  25. Diabetes Obes Metab

    Development and external validation of an algorithm for self‐identification of risk for microvascular complications in patients with type 1 diabetes

    Diagnostic or prognostic studyComplications

  26. Diabetes Obes Metab

    Comparison of the impact of type 1 and type 2 diabetes on quality of life of families of patients: A UK cross‐sectional study

    Cross-sectional study

  27. Diabetes Obes Metab

    The prognostic impact of the Stress Hyperglycemia Ratio on End‐Stage Renal Disease among patients with Diabetic Kidney Disease

    Cohort studyComplications

  28. Diabetes Obes Metab

    One or two? Comparison of the cardiorenal effects between combination therapy and monotherapy with SGLT2i or GLP1RA

    Meta-analysisT2D & other

  29. Diabetes Obes Metab

    Incidence of diabetes mellitus following hospitalisation for COVID ‐19 in the United Kingdom: A prospective observational study

    Cohort studyT2D & other

  30. Diabetes Obes Metab

    Relationship between trajectory of Chinese visceral adiposity index and risk of type 2 diabetes mellitus: Evidence from the China ‐ PAR project

    Cohort studyT2D & other

  31. Diabetes Obes Metab

    Circulating inflammatory proteins are elevated in type 1 and type 2 diabetes and associated to complications

    Cross-sectional studyComplications

  32. Diabetes Obes Metab

    Increased gallbladder emptying and reduced GLP ‐1 response in pregnancy with and without gestational diabetes mellitus

    Cohort studyDiabetes in pregnancy

  33. Diabetes Obes Metab

    De‐intensification of basal‐bolus therapy by replacing prandial insulin with once‐weekly subcutaneous semaglutide in individuals with well‐controlled type 2 diabetes: A single‐centre, open‐label randomised trial ( TRANSITION ‐ T2D )

    Randomized controlled trialT2D & other

  34. Diabetes Obes Metab

    Increased cardiovascular risk in people with LADA in comparison to type 1 diabetes and type 2 diabetes: Findings from the DPV registry in Germany and Austria

    Cross-sectional studyT2D & other

  35. Diabetes Obes Metab

    Long‐term all‐cause mortality of metabolic‐dysfunction associated steatotic liver disease based on body weight phenotypes following acute myocardial infarction: A retrospective cohort study

    Cohort studyLipids & liver

  36. Diabetes Obes Metab

    Targeting the cholinergic anti‐inflammatory pathway for type 2 diabetes prevention: A retrospective cohort study

    Cohort studyT2D & other

  37. Diabetes Obes Metab

    The cumulative impact of type 2 diabetes and obstructive sleep apnoea on cardiovascular, liver, diabetes‐related and cancer outcomes

    Cohort studyT2D & other

  38. Diabetes Obes Metab

    Effect of smoking behaviour and related blood DNA methylation on visceral adipose tissues

    Research articleT2D & other

  39. Diabetes Obes Metab

    Semaglutide improved sperm morphology in obese men with type 2 diabetes mellitus and functional hypogonadism

    Randomized controlled trialObesity

  40. Diabetes Obes Metab

    The association between android‐to‐gynoid lean mass ratio and all‐cause and specific‐cause mortality in US adults: A prospective study

    Cohort study

All 2,200 Briefs in ExploreShowing Briefs 1,321–1,360 of 2,200, newest first